STAT3 has been suggested to be one of the most important downstream signaling partners of EGFRvIII in tumorigenesis, and many studies have implicated EGFRvIII-STAT3 signaling in the progression of glioblastoma [31,32]. The gene discussed is STAT3; the disease is glioblastoma.